ASND beat EPS expectations by 34.50%
Feb 13, 2025, 11:31 PM
0.00%
What does ASND do
Ascendis Pharma A/S is a global biopharmaceutical company developing drug candidates for growth hormone deficiency, endocrinology, CNS disorders, infectious diseases, and diabetes. It operates through multiple subsidiaries in Germany and Denmark.
Ascendis Pharma A/S (ASND) reported a positive EPS surprise in its most recent quarterly earnings. For the most recent quarter, Ascendis Pharma A/S's actual EPS was -$0.64, beating the estimate of -$0.98 per share, resulting in a 34.50% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.